Frequent urination from 2-FMA

Frequent urination (pollakiuria) during psychoactive substance use refers to an increased need to void the bladder that exceeds normal frequency, which is typically four to eight times per day for healthy adults. The increase may involve larger volumes of urine (polyuria, due to true diuretic effects) or frequent passage of small volumes (due to bladder irritation or detrusor muscle hyperactivity).

Several distinct mechanisms produce increased urinary frequency. True diuresis occurs when substances increase urine production by the kidneys. Alcohol achieves this by suppressing antidiuretic hormone (ADH/vasopressin) secretion from the posterior pituitary, resulting in reduced water reabsorption in the collecting ducts and increased urine output. Caffeine produces mild diuresis through adenosine receptor antagonism in the kidneys and increased renal blood flow. These diuretic effects contribute to dehydration if fluid intake does not compensate for the increased output.

Bladder irritation represents a different and potentially more serious mechanism. Ketamine and its metabolites (particularly norketamine) are excreted through the urinary tract and are directly toxic to the urothelium -- the specialized lining of the bladder. Chronic or heavy ketamine use can cause ketamine-induced ulcerative cystitis, a progressive condition characterized by bladder wall thickening, fibrosis, reduced bladder capacity, severe urgency and frequency, and in advanced cases, bladder pain so severe that surgical bladder reconstruction is required. This is one of the most serious long-term health consequences of chronic ketamine use.

Some stimulants increase urinary frequency through sympathetic activation of the detrusor muscle and bladder sphincter. Psychedelics occasionally produce increased urination as part of general autonomic arousal during the come-up phase. GHB at lower doses can produce diuresis. Cannabis at high doses may alter the sensation of bladder fullness, causing more frequent trips to the bathroom.

For acute substance-related urinary frequency, maintaining adequate fluid intake and having easy bathroom access is sufficient management. For ketamine users, limiting frequency and dose of use is critical for bladder health. Any individual experiencing persistent urinary symptoms -- pain, blood in urine, dramatically reduced capacity -- after ketamine use should seek urological evaluation immediately, as early intervention can prevent irreversible damage.